NCGS patients were found to be enriched for IgG4 antibodies (an IgG subclass with weak immuno-stimulatory properties) while CeD patients were enriched for IgG1 and IgG3 subclasses, which are highly immuno-stimulatory. The gene discussed is IGHG3; the disease is cranioectodermal dysplasia.